Iron deficiency decreases hemolysis in sickle cell anemia;Anemia ferropriva diminui hemólise em anemia falciforme

Revista Brasileira de Hematologia e Hemoterapia

Volumn 31, Issue 1, 2009, Pages 51-53

  Castro, Oswaldo ^a   Medina, Adriana ^b   Gaskin, Peter ^b   Kato, Gregory J ^c   Gordeuk, Victor R ^b  

^a HOWARD UNIVERSITY   (United States)

^b HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Hemolysis; Iron deficiency; Sickle cell anemia

Indexed keywords

EID: 67650691305     PISSN: 15168484     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1516-84842009005000009     Document Type: Article

References (16)

1. Kato GJ, McGowan V, Machado RF, Little JA, Taylor J 6th, Morris CR, et al. Lactate dehydrogenase as a biomarker of hemolysis associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease. Blood. 2006;107(6):2279-85.
2. Jeffers A, Gladwin MT, Kim-Shapiro DB. Computation of plasma hemoglobin nitric oxide scavenging in hemolytic anemias. Free Radic Biol Med. 2006;41(10):1557-65.
3. Eaton WA, Hofrichter J. Hemoglobin S gelation and sickle cell disease. Blood. 1987;70(5):1245-66.
4. Lincoln TL, Aroesty J, Morrison P. Iron-deficiency anemia and sickle-cell disease: a hypothesis. Lancet. 1973;2(7823):260-1.
5. Koduri PR. Iron in sickle cell disease: a review why less is better. Am J Hematol. 2003;73(1):59-63.
6. Castro O, Haddy TB. Improved survival of iron-deficient patients with sickle erythrocytes. N Engl J Med. 1983;308(9):527.
7. Ballas SK, Marcolina MJ. Determinants of red cell survival and erythropoietic activity in patients with sickle cell anemia in the steady state. Hemoglobin. 2000;24(4):277-86.
8. Castro O, Poillon WN, Finke H, Massac E. Improvement of sickle cell anemia by iron-limited erythropoiesis. Am J Hematol. 1994; 47 (2):74-81.
9. King L, Reid M, Forrester TE. Iron deficiency anaemia in Jamaican children, aged 1-5 years, with sickle cell disease. West Indian Med J. 2005;54(5):292-6.
10. Bouchair N, Manigne P, Kanfer A, Raphalen P, de Montalembert M, Hagage I, et al. Prèvention des crises douloureuses drèpanocytaires par saignees itèratives. Arch Pèdiatr 2000;7:249-55
11. Rombos Y, Tzanetea R, Kalotychou V, Konstantopoulos K, Simitzis S, Tassiopoulos T, et al. Amelioration of painful crises in sickle cell disease by venesections. Blood Cells Mol Dis. 2002;28(2):283-7.
12. Markham MJ, Lottenberg R, Zumberg M. Role of phlebotomy in the management of hemoglobin SC disease: case report and review of the literature. Am J Hematol. 2003;73(2):121-5.
13. Benedict SL, Bonkowsky JL, Thompson JA, Van Orman CB, Boyer RS, Bale JF Jr, et al. Cerebral sinovenous thrombosis in children: another reason to treat iron deficiency anemia. J Child Neurol. 2004;19(7):526-31.
14. Balci K, Utku U, Asil T, Büyükkoyuncu N. Deep cerebral vein thrombosis associated with iron deficiency anaemia in adults. J Clin Neurosci. 2007;14(2):181-4.
15. Ni Z, Morcos S, Vaziri ND. Up-regulation of renal and vascular nitric oxide synthase in iron-deficiency anemia. Kidney Int. 1997; 52 (1):195-201.
16. Choi JW, Pai SH, Kim SK, Ito M, Park CS, Cha YN. Iron deficiency anemia increases nitric oxide production in healthy adolescents. Ann Hematol. 2002;81(1):1-6.